Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
531 questions in 102 reviews · Gynaecology and Fertility
current versionsNo studies 531 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Oral progestogen (dienogest, desogestrel) vs goserelin acetate Fibroid size · women with uterine fibroids Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative… (2020) · Cochrane | no estimate extracted | NR | No studies |
Levonorgestrel‐releasing intrauterine device vs low dose combined oral contraceptive Adverse events · women with uterine fibroids Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative… (2020) · Cochrane | no estimate extracted | NR | No studies |
Levonorgestrel‐releasing intrauterine device vs oral progestogen (norethisterone acetate) Fibroid size · women with uterine fibroids Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Congenital abnormalities per live birth · couples undergoing assisted reproduction treatment Regular (ICSI) versus ultra‐high magnification (IMSI) sperm selection for assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic treatment vs diagnostic laparoscopy Live birth · women with endometriosis Laparoscopic surgery for endometriosis (2020) · Cochrane | no estimate extracted | NR | No studies |
UAE/UACE vs systemic MTX Time to normalize β‐hCG · women with CSP Interventions for non‐tubal ectopic pregnancy (2020) · Cochrane | no estimate extracted | NR | No studies |
Suction curettage under hysteroscopy vs under ultrasonography Blood loss · women with CSP Interventions for non‐tubal ectopic pregnancy (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Adverse effects associated with hormones · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Withdrawal secondary to adverse effects · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Satisfaction · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Cost of treatment · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Adverse effects associated with LNG‐IUS · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG vs no treatment Hysterectomy · women with endometrial hyperplasia Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Ectopic pregnancy · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Multiple pregnancy · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Preterm delivery · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Foetal abnormalities · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Live birth/ongoing pregnancy · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Embryo culture supernatant vs culture medium injection Miscarriage · Subfertile women undergoing assisted reproduction Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
G‐CSF vs no treatment or placebo Multiple pregnancy rate · subfertile women undergoing assisted reproduction Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction (2020) · Cochrane | no estimate extracted | NR | No studies |
Combined oral contraceptive pill vs levonorgestrel‐releasing intrauterine system Other primary menstrual bleeding outcomes: semi‐objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Combined oral contraceptive pill vs contraceptive vaginal ring Other primary menstrual bleeding outcomes: objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Contraceptive vaginal ring vs progestogens Other primary menstrual bleeding outcomes: objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Contraceptive vaginal ring vs progestogens Adverse events · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Combined oral contraceptive pill vs placebo Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Combined oral contraceptive pill vs non‐steroidal anti‐inflammatory drugs Other primary menstrual bleeding and satisfaction outcomes: semi‐objectively assessed menstrual blood loss, subjectively assessed menstrual blood loss, participant satisfaction with treatment · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Combined oral contraceptive pill vs non‐steroidal anti‐inflammatory drugs Adverse events · heavy menstrual bleeding Combined hormonal contraceptives for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs ethamsylate (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs danazol (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs oral progestogens (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs progesterone‐releasing intrauterine system (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs oral contraceptive pill (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs oral contraceptive pill (control) Days of bleeding · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Mefenamic acid vs naproxen Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo (control) Number of days' bleeding · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs tranexamic acid (control) Quality of life · women with heavy menstrual bleeding Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Progestogen therapy long cycle (3 to 4 weeks) vs other medical therapy Quality of life · women with heavy menstrual bleeding Cyclical progestogens for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Progestogen therapy long cycle (3 to 4 weeks) vs other medical therapy Days of bleeding · women with heavy menstrual bleeding Cyclical progestogens for heavy menstrual bleeding (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs non‐steroidal anti‐inflammatory drugs (NSAIDs) Overall menstrual symptoms ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs non‐steroidal anti‐inflammatory drugs (NSAIDs) Restriction of daily life activities ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs non‐steroidal anti‐inflammatory drugs (NSAIDs) Quality of life ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs no treatment Use of rescue analgesic medication ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs no treatment Restriction of daily life activities ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs no treatment Absence from work or school ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs non‐steroidal anti‐inflammatory drugs (NSAIDs) Adverse events ‐ not reported · young women with suspected primary dysmenorrhoea Exercise for dysmenorrhoea (2019) · Cochrane | no estimate extracted | NR | No studies |
Swim‐up technique vs gradient technique Live birth rate per couple · patients undergoing intrauterine insemination (fresh semen) Semen preparation techniques for intrauterine insemination (2019) · Cochrane | no estimate extracted | NR | No studies |
Gradient technique vs wash and centrifugation Live birth rate per couple · patients with undergoing intrauterine insemination (fresh semen) Semen preparation techniques for intrauterine insemination (2019) · Cochrane | no estimate extracted | NR | No studies |
Gradient technique vs wash and centrifugation Ongoing pregnancy rate per couple · patients with undergoing intrauterine insemination (fresh semen) Semen preparation techniques for intrauterine insemination (2019) · Cochrane | no estimate extracted | NR | No studies |
Swim‐up technique vs wash and centrifugation Live birth rate per couple · patients undergoing intrauterine insemination (fresh semen) Semen preparation techniques for intrauterine insemination (2019) · Cochrane | no estimate extracted | NR | No studies |